Structural biomarkers identifiable on OCT-A can provide details regarding the development and progression of structural changes in MacTel 2.

Posterior vitreous detachment (PVD) occurs when the vitreous—a gel-like fluid in the eye—detaches from the retina. This results in eye floaters ... in the corners of your eyes and appear in your ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye disorder. But more work is needed to translate the treatment to people.

in dim light your peripheral vision is better than your central vision, or what you’re looking at directly. This is because of where certain photoreceptors are located on your retina (back of ...

Zhang says that the appearance of fatty lipid and protein deposits under the retina is a hallmark of dry AMD. Character’s data confirm that lipid transport machinery is associated with the ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving healthy ones intact. Unity Biotechnology announced topline results from its ...

Age is the most significant risk factor for macular degeneration. Being 50 or older increases ... that it causes an affected person to become legally blind while preserving peripheral vision.

Only two eyes had peripheral retinitis of ring morphology with central ... It is usually described in macular telangiectasia and has also been reported in infectious uveitis like toxoplasmosis and ...

The FDA has approved the first – and only – treatment, a cell therapy, for macular telangiectasia type 2 (MacTel), a ... blurriness and distortion, although peripheral vision remains intact. It ...